Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 2.3%

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH)’s stock price fell 2.3% during trading on Friday . The stock traded as low as $0.38 and last traded at $0.39. 27,512 shares were traded during mid-day trading, a decline of 77% from the average session volume of 119,612 shares. The stock had previously closed at $0.40.

Shuttle Pharmaceuticals Stock Performance

The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.37 and a current ratio of 5.37. The stock has a market cap of $6.55 million, a PE ratio of -0.91 and a beta of -1.13. The company’s 50 day simple moving average is $0.41 and its 200 day simple moving average is $0.45.

Shuttle Pharmaceuticals (NASDAQ:SHPH) last posted its quarterly earnings data on Thursday, March 21st. The company reported ($0.10) EPS for the quarter.

Shuttle Pharmaceuticals Company Profile

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers.